Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Physical Activity Levels During Recovery Following Knee Arthroplasty

23. juli 2020 oppdatert av: University of Oxford

Identifying the Trajectory of Normal Recovery Following Knee Arthroplasty Through Physical Activity Monitoring Via Wrist-Worn Accelerometry

The goal of this study is to utilize physical activity monitoring to determine the trajectory of normal recovery as it relates to a patient's ability to get up and get moving. From this work, we hope to be able to define the range in patients' physical activity following knee replacement surgery, and thus, give clinicians a tool and the methodology to identify patients whose recovery is not progressing as quickly as expected. Data from physical activity monitors will allow the research team to identify how active patients are, how vigorous that activity is, and how well that activity correlates with standard and commonly used patient questionnaires.

Studieoversikt

Status

Ukjent

Detaljert beskrivelse

This study is an observational study of the physical activity levels of adults who have been diagnosed with end-stage osteoarthritis of the knee and are undergoing knee replacement surgery at the Nuffield Orthopaedic Centre, Oxford. Data regarding patient activity and functional recovery will be collected using two methods. First, data will be collected through the extraction of three-axis accelerometer data, collected via a wrist-worn (and hip-worn for a subset of patients) physical activity monitor. This data will be collected in three intervals: pre-operatively, immediately postoperatively, and at 6 months postoperatively. Secondly, data will be collected by standard clinical assessment and patient reported outcome measures. These assessments will again take place pre-operatively, at 6 weeks postoperatively, and at 6 months postoperatively. Additional data will be collected through a simple activity diary, which asks the participants to log their monitor wear-time along with the times that they took bicycle rides or extended walks.

The expected duration of patient involvement is up to a total of 8 to 8.5 weeks over the course of up to 7 months. There are no clinical visits within this protocol beyond what is already within normal patient care. Patients will be asked to post their monitor back to the research centre for data collection and data processing twice during the study period.

The aim of this study is to assess the trajectory of recovery in terms of physical activity in the post-operative knee replacement population, and subsequently to define the expected path of early recovery.

Studietype

Observasjonsmessig

Registrering (Forventet)

400

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Oxfordshire
      • Oxford, Oxfordshire, Storbritannia, OX3 7LD
        • Rekruttering
        • Nuffield Orthopaedic Centre, Oxford University Hospitals Trust
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew J Price, DPhil, FRCS
        • Underetterforsker:
          • Scott R Small, MS
        • Underetterforsker:
          • Karen L Barker, PhD, FCSP
        • Underetterforsker:
          • Sara Khalid, DPhil

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Participants will be patients undergoing primary total or unicompartmental knee arthroplasty for treatment of end-stage osteoarthritis.

Beskrivelse

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 years or above.
  • Diagnosed with required late stage osteoarthritis, undergoing knee arthroplasty in the next 3 months.
  • In Investigator's opinion, is able and willing to comply with all trial requirements.

Exclusion Criteria:

  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
  • Participants who are enrolled in another research study involving an investigational product or methodology that could alter physical activity.
  • Participants are undergoing a revision arthroplasty surgery on the operative knee

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Knee Arthroplasty Patient
Patients undergoing primary total or unicompartmental knee arthroplasty for treatment of end-stage osteoarthritis.
Reconstruction of part or all of the native articulation at the knee joint via implant.
Andre navn:
  • Knee Replacement

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in physical activity
Tidsramme: Physical activity will be evaluated for 7 days at approximately 2 weeks before surgery, for 6 continuous weeks immediately postoperatively and (for a subset of participants) for 7 continuous days at 6 months postoperatively.
The primary outcome measure will physical activity, as extracted from analysis of raw accelerometer data from the activity monitor. Several variables will be extracted from the raw data, including average acceleration vector (Euclidean norm minus one), bouts of physical activity and percentage of active and sedentary time.
Physical activity will be evaluated for 7 days at approximately 2 weeks before surgery, for 6 continuous weeks immediately postoperatively and (for a subset of participants) for 7 continuous days at 6 months postoperatively.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Oxford Knee Score
Tidsramme: Pre-operative (baseline), 6 weeks, 6 months
A patient reported outcome measure to assess patient benefit [Range 0 to 48, higher scores corresponding to better outcomes].
Pre-operative (baseline), 6 weeks, 6 months
Change in EQ-5D-5L
Tidsramme: Pre-operative (baseline), 6 weeks, 6 months
A patient reported outcome measure to assess patient benefit. As summary index score from 0 to 1 is given, where 0 is the health state equivalent to dead, 1 is a full healthy outcome, and negative indicates a health state worse than dead. The score is derived from five sections (Mobility, Self-Care, Usual Activities, Pain/Discomfort, Anxiety/Depression) scored 1 to 5, with higher corresponding to better outcomes. A second visual analogue score for perceived health is reported from 0 to 100 with higher scores indicating better perceived overall health.
Pre-operative (baseline), 6 weeks, 6 months
Change in University of California, Los Angeles (UCLA) Activity Score
Tidsramme: Pre-operative (baseline), 6 weeks, 6 months
A self-reported score to assess patient benefit and physical activity. The score ranges from 1 to 10 where higher scores indicate greater levels of physical activity
Pre-operative (baseline), 6 weeks, 6 months
Change in International Physical Activity Questionnaire Questionnaire - Short Form
Tidsramme: Pre-operative (baseline), 6 weeks, 6 months
A self-reported score to assess patient benefit and physical activity. The score can be reported in one of three categories: Low, Moderate, or High physical activity.
Pre-operative (baseline), 6 weeks, 6 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Scott R Small, MS, University of Oxford

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

31. januar 2020

Primær fullføring (Forventet)

1. juni 2021

Studiet fullført (Forventet)

1. oktober 2021

Datoer for studieregistrering

Først innsendt

22. januar 2020

Først innsendt som oppfylte QC-kriteriene

22. januar 2020

Først lagt ut (Faktiske)

27. januar 2020

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

27. juli 2020

Siste oppdatering sendt inn som oppfylte QC-kriteriene

23. juli 2020

Sist bekreftet

1. juli 2020

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • IRAS 260855
  • 19/SW/0151 (Annen identifikator: NHS Health Research Authority)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified individual participant data for all primary and secondary outcome measures will be made available.

IPD-delingstidsramme

Data will be made available within 6 months following study completion.

Tilgangskriterier for IPD-deling

Data access requests will be reviewed by the trial steering committee.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE
  • ICF

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere